Director, Interventional Cardiology and Cardiac Catheterization Laboratories
Professor of Medicine

E-Mail

Hospital of The University of Pennsylvania
Department of Medicine
Cardiovascular Medicine Division
9.120 Founders Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283

Appointments
Contact: Renee Brown (215) 662-2180

Clinical Specialty:

• Cardiovascular Medicine

Practice Location:

• Hospital of The University of Pennsylvania, Founders Pavilion

Education:

• MD: Harvard Medical School
• Residency: Massachusetts General Hospital, Boston, MA
• Fellowship: Massachusetts General Hospital, Boston, MA

Research Interest:

• Cardiac Catheterization
• Angioplasty and Stents
• Myocardial Infarction
• Balloon Valvuloplasty
• Mitral Valve Disease
• Catheter Closure of Patent Foramen Ovale and Atrial Septal Defects
• New Platelet Inhibitors
• Cardiovascular Effects of Viagra

Selected Publications:

1. Herrmann HC. Triple Therapy for Acute Myocardial Infarction: Combining Fibrinolysis, Platelet IIb/IIIa Inhibition, and Percutaneous Coronary Intervention. Am J Cardiol 2000;85:10C-16C.
2. Herrmann HC. New Approaches to Revascularization in Acute Myocardial Infarction and Stroke: Introduction. Am J Cardiol 2000;85:1C.
3. Herrmann HC, Moliterno DJ, Ohman EM, Stebbins AL, Bode C, Betriu A, Forycki F, Miklin JS, Bachinsky WB, Lincoff AM, Califf RM, Topol EJ. Facilitation of Early Percutaneous Coronary Intervention After Reteplase With or Without Abciximab in Acute Myocardial Infarction: Results from the SPEED (GUSTO-IV) Pilot) Trial. J Am Coll Cardiol 2000; 36:1489-1496.
4. Herrmann HC, Chang G, Klugherz BD, Mahoney PD. Hemodynamic Effects of Oral Sildenafil Citrate in Men With Severe Coronary Disease. New Engl J Med 2000;342:1622-6.
5. Herrmann HC. Editor: New Approachs to Revascularization in Acute Myocardial Infarction and Stroke. Am J Cardiol supplement 2000;85:1C-51C.
6. Herrmann HC, Li RH, Ohman EM. Facilitated Percutaneous Coronary Intervention: Results from the SPEED Trial. Eur Heart J 2001;3 (Suppl A): A26-A34.
7. Herrmann HC, Kelley MP, Ellis SG. Facilitated PCI: Rationale and Design of the FINESSE Trial. J Inv Cardiol 2001;13 (suppl A) : 10A-15A.
8. Topol EJ, Moliterno DJ, Herrmann HC, et al. Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for Prevention of Ischemic Events with Percutaneous Coronary Intervention. New Engl J Med 2001;344:1888-94.
9. Herrmann HC, Swierkosz TA, Kapoor S, Tardiff DC, DiBattiste PM, Hirshfeld JW, Klugherz BD, Kolansky DM, Magness K, Valettas N, Wilensky RL. Comparison of Degree of Platelet Inhibition by Abciximab-vs-Tirofiban in Patients With Unstable Angina and Non-Q-Wave Myocardial Infarction Undergoing Percutaneous Coronary Interventions. Am J Cardiol 2002;89:1293-97.
10. Herrmann HC. Comparison of Angioplasty with Stenting in Acute Myocardial Infarction. N Engl J Med 2002;347:367 (letter).
11. Herrmann HC, Rohatgi S, Wasserman H, Block P, … Feldman T.  Mitral Valve Hemodynamic Effects of Percutaneous Edge-to-Edge Repair with the MitraClip Device for Mitral Regurgitation.  Catheter Cardiovasc Intervention 2006;68:821-828.
12. Herrmann HC, Silvestry FM, Glaser R, See V, Kasner S, Bradbury D, Chang G, Hirshfeld JW, Horwitz PA, Kelly M.   Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure in Adults:  Results and Device Comparison in 100 Consecutive Implants at a Single Center.  Cath and Cardiovasc Interven 2005;64:197-203.
13. Herrmann HC and Feldman T.  Percutaneous Mitral Valve Edge-to-Edge Repair With the Evalve MitraClip System:  Rationale and Phase 1 Results.  EuroIntervention 2006;1 (supplement A): A36-A39.H
14. Herrmann HC.  Percutaneous Valve Therapies.  Current Treatment Options in Cardiovascular Medicine 2005;7:477-482.